Skip to main content
. Author manuscript; available in PMC: 2016 Sep 7.
Published in final edited form as: Biometrics. 2016 Jan 12;72(3):897–906. doi: 10.1111/biom.12470

Table 1.

Summary of predictive accuracy estimates for five models of interest. Lasso-Cox1: censoring weights are estimated from a Cox PH model using the selected variables based on a Lasso-Coxph model. Lasso-Cox2: censoring weights are estimated directly from a Lasso-Cox model.

Model
c^s2(SD)
c^g2(SD)
c^s2(SD)
c^g2(SD)
c^s2(SD)
c^g2(SD)
tQ25=16(month) tQ75=68(month) tMAX=164(month)
Lasso-Cox1
Model I 0.599(0.053) 0.599(0.054) 0.587(0.049) 0.590(0.052) 0.588(0.050) 0.589(0.056)
Model II 0.561(0.097) 0.561(0.097) 0.540(0.068) 0.541(0.068) 0.539(0.065) 0.543(0.068)
Model III 0.723(0.072) 0.723(0.071) 0.705(0.056) 0.707(0.057) 0.704(0.055) 0.710(0.058)
Model IV 0.683(0.070) 0.680(0.071) 0.666(0.055) 0.672(0.057) 0.666(0.054) 0.668(0.059)
Model V 0.670(0.075) 0.665(0.076) 0.638(0.058) 0.638(0.060) 0.641(0.057) 0.638(0.061)
Lasso-Cox2
Model I 0.599(0.053) 0.577(0.103) 0.587(0.049) 0.545(0.084) 0.588(0.050) 0.546(0.084)
Model II 0.561(0.097) 0.550(0.124) 0.540(0.068) 0.528(0.098) 0.539(0.065) 0.528(0.098)
Model III 0.723(0.072) 0.726(0.095) 0.705(0.056) 0.715(0.081) 0.704(0.055) 0.715(0.081)
Model IV 0.683(0.070) 0.669(0.101) 0.666(0.055) 0.663(0.080) 0.666(0.054) 0.663(0.080)
Model V 0.670(0.075) 0.600(0.116) 0.638(0.058) 0.579(0.089) 0.641(0.057) 0.580(0.088)

Model I: only PSA and Gleason;

Model II: PSA, Gleason and biomarkers 2,4,8,11,14,16,22,31,46,52,63 based on Long et al. (2011);

Model III: PSA, Gleason and biomarkers 2,3,5,6,7,13,15,26,32,43,56,83 from all 1536 biomarkers;

Model IV: PSA, Gleason and biomarkers 2,5,6,7,10,13,15 from the top 25 biomarkers;

Model V: PSA, Gleason and biomarkers 2,5,6,7,10 from the top 10 biomarkers;